Multiple Sclerosis Channel
Topics & Medications
Related Channels

Novantrone Warnings and Precautions

Reviewing your medical history and current medications with your healthcare provider before starting treatment with Novantrone can help minimize potentially serious complications. Safety precautions with Novantrone include warnings of heart problems and low blood cell counts. Also, people who have certain allergies or women who are pregnant or breastfeeding may not be able to use this medicine.


What Should I Tell My Healthcare Provider?

You should talk with your healthcare provider prior to taking Novantrone® (mitoxantrone) if you have:
  • Kidney disease, such as kidney failure (renal failure)
  • Liver disease, such as hepatitis, cirrhosis, or liver failure
  • Heart problems, such as congestive heart failure
  • Bone marrow problems
  • Low blood cell counts
  • Anemia
  • Frequent infections, or currently have an infection
  • Had cancer treatment or radiation treatment in the past
  • Any allergies, including to foods, dyes, or preservatives.
In addition, let your healthcare provider know if you are:
  • Pregnant or thinking of becoming pregnant
  • Breastfeeding.
You should also tell your healthcare provider about all other medications you are taking, including prescription and nonprescription medicines, vitamins, and herbal supplements.

Specific Precautions and Warnings for Novantrone

Some warnings and precautions to be aware of prior to taking this drug include the following:
  • This medicine is dark blue in color and can cause your urine to temporarily turn bluish-green for 24 hours after each dose. The whites of your eyes may also appear bluish in color for 24 hours.
  • Novantrone can cause myelosuppression, which is a decrease in the ability of the bone marrow to make blood cells. Myelosuppression can lead to abnormally low levels of white blood cells, red blood cells, and platelets, which could increase your risk for infections, anemia, and bleeding problems. You may need blood tests during treatment to check your blood cell counts. Let your healthcare provider know if you have signs of this complication, such as:
    • Abnormal or easy bleeding or bruising
    • Fatigue or shortness of breath
    • Frequent infections.
  • Novantrone can cause heart problems, including congestive heart failure, which can be severe enough to lead to death. Heart problems can develop during treatment, or even years later, and can even occur in people who have never had heart problems before. Your healthcare provider will order tests to check how well your heart works during treatment. If you use this medicine for multiple sclerosis (MS), you will need to have yearly heart monitoring even after you stop using it.
  • Because the risk for heart problems increases with the total amount of medication given, people being treated for MS have a limit on the total amount of Novantrone they should receive over their lifetime.
  • It is unknown whether Novantrone is safe for use in people with liver disease. Make sure your healthcare provider knows if you have liver problems before starting treatment.
  • This medicine must only be given as an injection into a vein (intravenous, or IV, injection). There have been reports of serious side effects occurring when it was given as an injection under the skin (subcutaneous) or into an artery (intra-arterial), muscle (intramuscular), or the spinal fluid (intrathecal). These side effects have included nerve damage, seizures, and coma.
  • This medicine may increase your risk for developing a type of leukemia known as acute myeloid leukemia (AML). Let your healthcare provider know if you develop signs of AML, such as:
    • Easy bleeding or bruising
    • Frequent infections
    • Fever
    • Bone pain
    • Unexplained weight loss
    • Night sweats.
  • Novantrone is a pregnancy Category D medication, which means it may harm an unborn child. Women of childbearing potential who are receiving this medicine for MS should have a negative pregnancy test before each dose (see Novantrone and Pregnancy).
  • Novantrone passes through breast milk. Therefore, if you are breastfeeding or plan to start, discuss this with your healthcare provider prior to receiving the drug (see Novantrone and Breastfeeding).
5 Easy Tips to Manage Visitors During Cancer Treatment

Novantrone Medication Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.